| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,848 |
3,537 |
$338K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
524 |
493 |
$72K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,916 |
1,163 |
$41K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
247 |
239 |
$28K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
595 |
298 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
116 |
111 |
$7K |
| 90461 |
|
227 |
204 |
$6K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
68 |
54 |
$5K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
42 |
42 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
120 |
119 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
138 |
133 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
14 |
14 |
$2K |
| 85018 |
|
703 |
675 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
26 |
$1K |
| 94760 |
|
591 |
554 |
$688.83 |
| 90686 |
|
159 |
157 |
$148.66 |
| 83655 |
|
12 |
12 |
$79.92 |
| 36415 |
Collection of venous blood by venipuncture |
19 |
19 |
$46.20 |
| 36416 |
|
268 |
234 |
$0.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 96127 |
|
18 |
15 |
$0.00 |
| 99173 |
|
178 |
158 |
$0.00 |
| 90671 |
|
13 |
13 |
$0.00 |